98%
921
2 minutes
20
Objective: Stereotactic laser amygdalohippocampotomy (SLAH) is a minimally invasive procedure for mesial temporal lobe epilepsy that preserves more tissue than open procedures. As a result, although patients have better functional outcomes, more patients do not achieve seizure freedom. The rate at which this occurs is evolving with improved surgical practices. However, the risks and benefits of further surgical management for these patients remains a question with limited data to guide decision-making.
Methods: We retrospectively reviewed a continuous series (2011-2019) of SLAH operations at our institution to determine trends in surgical management, identifying cases where further surgery was performed. Pre-operative and follow-up seizure, cognitive, and functional data, and surgical complications were collated.
Results: Of 108 patients undergoing primary SLAH, 21 (19%) underwent further surgery (23 procedures). Stereo-electroencephalography (SEEG) informed seven procedures (30%). There was a trend for quicker SLAH failure in the earlier patients. Similarly, surgical chronology was associated with progression to repeat surgery (p = .007). At 1-year follow-up, 6 of 13 patients (46%) achieved seizure freedom after repeat SLAH and 5 of 8 patients (63%) achieved seizure freedom after anterior temporal lobectomy (ATL), one of whom had failed two SLAHs. Two of three patients undergoing an ablation outside the mesial temporal lobe achieved seizure freedom at 1 year. Neuropsychological sequelae were more prevalent with ATL than SLAH, including decline in visual naming (p = .01) and functional status (p = .007).
Significance: Repeat SLAH and ATL post-SLAH are both practicable and can be effective. Surgical experience, risk to cognition, and marginal benefit relative to existing improvement are principal considerations for further surgery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/epi.18188 | DOI Listing |
Epileptic Disord
September 2025
Referral Center for Refractory Epilepsy, Epilepsy Surgery Program Group - ULS Coimbra, Coimbra, Portugal.
Objective: Despite pharmacological advances in epilepsy treatment, one-third of patients remain pharmacoresistant and may require surgery. Despite extensive literature on epilepsy surgery, studies with follow-ups longer than 5 years are rare. Our goal was to analyze the outcomes of patients undergoing epilepsy surgery at our center, with a minimum follow-up of 15 years.
View Article and Find Full Text PDFSeizure
August 2025
Department of Physiology and Pharmacology, Federal University of Pernambuco, Recife, PE, Brazil.
Background: To systematically evaluate the efficacy, safety, and tolerability of adjunctive lacosamide (LCM) in children and adolescents with drug-resistant epilepsy (DRE).
Methods: A systematic review and single-arm meta-analysis was conducted in accordance with PRISMA 2020 guidelines. MEDLINE, Embase, and Cochrane Library were searched up to April 2025.
J Neurosurg
September 2025
2Latin American Neurosurgical Collaborative for Excellence in Research, Ciudad de México, México.
Objective: Open resective surgery (ORS) has become the standard of care for focal drug-resistant epilepsy (DRE). However, minimally invasive surgical alternatives, such as laser interstitial thermal therapy (LITT), have also been shown to be safe and effective. A meta-analysis comparing both treatments is warranted to assess the benefits of each modality for focal DRE.
View Article and Find Full Text PDFEpilepsy affects around 1% of the global population and often requires long-term treatment with antiseizure medications (ASMs). However, the current treatment strategy is based on clinical acumen and trial and error, resulting in only about 50% of patients remaining seizure-free for at least 12 months with first-line ASMs. Valproic acid (VPA) is a commonly prescribed first-line ASM, yet <50% of patients experience inadequate seizure control (ISC) or unacceptable adverse reactions (UARs), necessitating discontinuation.
View Article and Find Full Text PDFEpilepsy Behav
September 2025
Professor of Cultural and Social Anthropology, Dept. of Literature, Art and History, Chieti-Pescara University, Via dei Vestini 31, Chieti, Italy. Electronic address:
To live with epilepsy is to inhabit a space of perpetual uncertainty-between seizures, between wellness and risk, between life and the threat of sudden death. This editorial reflects on two recent contributions to Epilepsy & Behaviour addressing SUDEP risk communication and the redefinition of healing in epilepsy. Drawing on anthropological and phenomenological perspectives, the article explores how epilepsy disrupts categories of time, agency, and identity, and how biomedical approaches often fail to grasp the moral and relational dimensions of such disruption.
View Article and Find Full Text PDF